GB9616986D0 - Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma - Google Patents

Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma

Info

Publication number
GB9616986D0
GB9616986D0 GBGB9616986.7A GB9616986A GB9616986D0 GB 9616986 D0 GB9616986 D0 GB 9616986D0 GB 9616986 A GB9616986 A GB 9616986A GB 9616986 D0 GB9616986 D0 GB 9616986D0
Authority
GB
United Kingdom
Prior art keywords
prophylactic
diagnosis
materials
cell carcinoma
therapeutic treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9616986.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GBGB9616986.7A priority Critical patent/GB9616986D0/en
Publication of GB9616986D0 publication Critical patent/GB9616986D0/en
Priority to PCT/GB1997/002209 priority patent/WO1998006871A1/en
Priority to AU40205/97A priority patent/AU4020597A/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB9616986.7A 1996-08-13 1996-08-13 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma Pending GB9616986D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9616986.7A GB9616986D0 (en) 1996-08-13 1996-08-13 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma
PCT/GB1997/002209 WO1998006871A1 (en) 1996-08-13 1997-08-13 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma
AU40205/97A AU4020597A (en) 1996-08-13 1997-08-13 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9616986.7A GB9616986D0 (en) 1996-08-13 1996-08-13 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma

Publications (1)

Publication Number Publication Date
GB9616986D0 true GB9616986D0 (en) 1996-09-25

Family

ID=10798420

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9616986.7A Pending GB9616986D0 (en) 1996-08-13 1996-08-13 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma

Country Status (3)

Country Link
AU (1) AU4020597A (en)
GB (1) GB9616986D0 (en)
WO (1) WO1998006871A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017524371A (en) * 2014-05-23 2017-08-31 ジェネンテック， インコーポレイテッド MIT biomarkers and methods of use
CN107267608B (en) * 2017-06-16 2018-03-09 中国人民解放军南京军区南京总医院 A kind of MATR3 TFE3 fusions and its detection primer and application
CN109321640A (en) * 2018-10-15 2019-02-12 南京艾迪康医学检验所有限公司 Detect oligonucleotides, method and the kit of PSF-TFE3 fusion in sample

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008854A1 (en) * 1987-05-06 1988-11-17 Egbert Oosterwijk Monoclonal antibodies to renal cell carcinoma

Also Published As

Publication number Publication date
WO1998006871A1 (en) 1998-02-19
AU4020597A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
GB0106183D0 (en) Improvements in or relating to the treatment of lesions
AU1920900A (en) Solid water treatment composition and methods of preparation and use
AU2160297A (en) Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
GB0015235D0 (en) Compositions for the treatment of skin and anorectal conditions
HUP9904047A3 (en) N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds
GB9418420D0 (en) Composition for the treatment of an energy imbalance in ruminents
IL128894A0 (en) Materials and methods relating to the diagnosis and treatment of diabetes and obesity
EP0756636A4 (en) Chondroitinases i and ii, methods of preparation, and use thereof
GB9523335D0 (en) Improvements in or relating to skin treatment materials
ZA954984B (en) Compositions and methods for the treatment of tumors
GB9814036D0 (en) Materials and methods relating to the induction of apoptosis in target cells
AU2734995A (en) Phytotherapeutic agent for treatment of skin lesions and morbid changes in the skin and method for its preparation
AU2986595A (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
GB9616986D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma
HUP9902802A3 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
IL120383A0 (en) Use of naphthalene derivatives in treating lung carcinoma
GB9606415D0 (en) Improvements in and relating to the generation of elecricity
GB9721075D0 (en) Materials and methods relating to the stimulation of cells
GB2337153B (en) Improvements in and relating to the collection of ions
GB9617961D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeuti treatment of cancer
ZA983455B (en) Treatment of renal cell carcinoma
AU4402497A (en) Methods and means for the treatment of malignancies